ArticleEnvironmental health and preventive medicine2026
Lessons learned from Okinawa, Japan underscore the importance of clinical epidemiology in COVID-19 prevention and control.
Article in Environmental health and preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis letter highlights the importance of clinical epidemiology in COVID-19 prevention and control, based on experiences at a core hospital in northern Okinawa, Japan, and relevant literature.
methodsUsing data from 5,097 COVID-19 patients, we conducted: (1) a descriptive cross-sectional study analyzing cases by person, time, and place; (2) an analytical cross-sectional study linking health checkup data to identify factors associated with severity (published in Environmental Health and Preventive Medicine); and (3) a cohort study of healthcare workers exploring determinants of post-vaccination antibody titers (published in Journal of Clinical Virology Plus).
resultsThe descriptive study showed cases rose from 70 in 2020 to 891 in 2021 and 3,995 in 2022, before declining to 141 in 2023. In the analytical cross-sectional study (n = 1,353), protective factors against severity included vaccination (odds ratio [OR] [2 doses vs. 0 or one doses]: 0.223, 95% confidence interval [CI] 0.114-0.436; OR [≥3 doses vs. 0 or one doses]: 0.090, 95% CI 0.035-0.229) and regular exercise (OR ["yes" vs. "no"]: 0.458, 95% CI 0.242-0.866). In the cohort study (n = 354), lower antibody titers (lowest quartile) were more likely among older adults (hazard ratio [HR] 5.82 for 40s vs. 20s, 95% CI 2.05-16.51; HR 9.96 for 60s vs. 20s, 95% CI 3.07-32.34) and drinking habits (HR 2.26 for "daily" vs. "never", 95% CI 1.17-4.34).
conclusionThese findings, supported by related literature, demonstrate that clinical epidemiology played vital roles in monitoring infection trends, evaluating diagnostic and preventive measures, establishing treatment strategies, optimizing healthcare resources, and guiding policy. Its continued application will be essential for preparedness against future emerging infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.